Targeting Bacterial DNA Gyrase-B with Fenugreek-Derived Phytochemicals: An In Silico Strategy for Antibacterial Lead Discovery
Science & Technology Asia · 30.06.2026 · 208-222
DOI: 10.70730/sta.v31i2.259792 ↗Kurz gefasst
Fachartikel in der Zeitschrift Science & Technology Asia, online erschienen am 30.06.2026. Verfasst von Daniel Bauta Musa und 3 weiteren Autor:innen. Die Arbeit nennt 39 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
Antibiotic resistance poses a major public health challenge globally. Fenugreek (Trigonella foenum-graecum) contains phytochemicals that have been studied for possible antibacterial activity. This study examines the interaction of fenugreek seed phytochemicals with DNA gyrase-B using computational methods. GC-MS was employed to identify bioactive compounds. Lipinski’s Rule of Five and Absorption, Distribution, Metabolism, Excretion, and Toxicity (ADMET) analyses were used to evaluate drug-likeness and pharmacokinetic properties. Selected ligands were docked with bacterial DNA gyrase-B using AutoDock Vina and analyzed using BIOVIA Discovery Studio. GC-MS revealed 29 compounds from the aqueous and methanolic extracts, 12 of which passed the drug -likeness screening. ADMET profiling indicated favorable ADMET profiles for several candidates. Molecular docking revealed that cyclodocosane, ethyl exhibited the highest binding affinity (-9.6 kcal/mol) against DNA gyrase-B. Although, only one specific hydrophobic interaction was observed. This hydrophobic contact involves a nonpolar amino acid residue (Leu294) in the binding pocket of the protein, key to maintaining the complex's integrity. This compound outperformed the standard drug ciprofloxacin (-9.2 kcal/mol). The result indicate that the ligand may serve as a starting point for further optimization. Fenugreek seeds contain phytochemicals with promising antibacterial potential, especially against DNA gyrase-B. Cyclodocosane, ethyl may serve as a lead compound for novel antibacterial drug development, pending further validation and optimization.
Zitieren
APA
Musa, D. B., Magaji, Y., Ozojiofor, U. O., & Vantsawa, P. A. (2026). Targeting Bacterial DNA Gyrase-B with Fenugreek-Derived Phytochemicals: An In Silico Strategy for Antibacterial Lead Discovery. Science & Technology Asia, 208-222. https://doi.org/10.70730/sta.v31i2.259792
Vancouver
Musa DB, Magaji Y, Ozojiofor UO, Vantsawa PA. Targeting Bacterial DNA Gyrase-B with Fenugreek-Derived Phytochemicals: An In Silico Strategy for Antibacterial Lead Discovery. Science & Technology Asia. 2026:208-222. doi:10.70730/sta.v31i2.259792
BibTeX
@article{Musa2026,
author = {Musa, Daniel Bauta and Magaji, Yakubu and Ozojiofor, Ugochukwu Okechukwu and Vantsawa, Patrick Anthony},
title = {Targeting Bacterial DNA Gyrase-B with Fenugreek-Derived Phytochemicals: An In Silico Strategy for Antibacterial Lead Discovery},
journal = {Science & Technology Asia},
year = {2026},
pages = {208--222},
doi = {10.70730/sta.v31i2.259792}
}
EUVIMED